Emergent BioSolutions | EBS - Ebitda





Ebitda تغيير تاريخ
Acadia Pharmaceuticals USD 20.31M 15.44M 2025-12
Akebia Therapeutics USD 14.03M 17.19M 2025-03
ALKERMES USD 139.22M 58.96M 2026-06
Alnylam Pharmaceuticals USD 245.34M 59.15M 2026-06
Amarin USD 12.54M 28.57M 2025-06
ANI Pharmaceuticals USD 65.36M 5.76M 2025-12
BioMarin Pharmaceutical USD 146.05M 170.22M 2026-03
Coherus Biosciences USD -43.33M 4.7M 2025-09
Exelixis USD 258.29M 15.43M 2026-03
Glaxosmithkline GBP 2.77B 1.98B 2026-03
Heron Therapeutics USD -3.88M 5.63M 2024-09
Ionis Pharmaceuticals USD -64.53M 135.49M 2026-03
Ironwood Pharmaceuticals USD 81.81M 31.71M 2025-09
Lexicon Pharmaceuticals USD -12.04M 15.95M 2025-09
Lonza CHF 1.01B 54M 2025-12
Merck USD 6.3B 2.09B 2025-12
Moderna USD -1.26B 468M 2026-03
Myriad Genetics USD 14.3M 4M 2025-12
Nektar Therapeutics USD -31.81M 70K 2023-09
Neurocrine Biosciences USD 193.3M 25.1M 2026-03
Pacira USD 40.24M 1.53M 2026-03
Pfizer USD 5.99B 5.23B 2026-03
PTC Therapeutics USD 61.98M 132.97M 2026-03
Sanofi EUR 3.69B 375M 2026-06
Sarepta Therapeutics USD -252.2M 84.16M 2025-12
United Therapeutics USD 379.5M 83.4M 2025-12
Vanda Pharmaceuticals USD -8.31M 2.37M 2024-12